Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Kaleido logo — Kaleido, insulin pump therapy designed to help you live life...

Kaleido

Kaleido, insulin pump therapy designed to help you live life on your own terms.

Founded 2013 The Netherlands The Netherlands 215 employees Series D Total: $170.40M Health Care, Medical Devices

General Information

Company Name Kaleido
Founded Year 2013
Location The Netherlands The Netherlands
Employees 215
Industries Health Care, Medical Devices
Funding Stage Series D
Business Model B2C, D2C, B2B2C
Revenue Model Product Sales, Subscription, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Kaleido. To contact Kaleido, visit hellokaleido.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Kaleido compare?

A PDF of Kaleido and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Kaleido soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Kaleido

Kaleido, the pioneering insulin pump therapy by ViCentra BV, embodies their slogan: "Kaleido, insulin pump therapy designed to help you live life on your own terms." Founded in 2013 in Utrecht, The Netherlands, the company is revolutionizing the healthcare industry by focusing on products that prioritize user experience.

Operating in the Health Care and Medical Devices sectors, ViCentra BV is dedicated to minimizing the daily challenges faced by individuals with diabetes. Kaleido stands out for its patient-centric approach, aiming to reduce the disease's impact on everyday life with its innovative design and functionality.

Recently, the company secured a $13.00 million Series D investment on 08 January 2026, backed by strategic investors including ROM Utrecht Region, Innovation Industries, and Venturing Tech. This funding round marks a significant milestone, underscoring investor confidence in Kaleido's potential to lead advancements in diabetic care.

Business keywords: Insulin Pump Therapy, Diabetes Management, Innovative Healthcare Products, User-Centric Design, Healthcare Product Commercialization, Early Stage Commercial Company, Human-Centric Design, Simplified Healthcare Solutions

Services & Products

Automated Insulin Delivery
Diabetes Data Insights
Customizable Wearable Pumps
Healthcare Consultation Support

Target Customers

Adults with Type 1 Diabetes Healthcare Providers Caregivers of Diabetic Patients

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $13.00M 3
ROM Utrecht Region Innovation Industries
ROM Utrecht Region, Innovation Industries +1
08 Jan 2026
Series D €72.40M 5
Invest-NL Health Innovations Innovation Industries
Invest-NL, Health Innovations +3
05 Sep 2025
Series C €65.00M 4
Inkef Health Innovations
Inkef, Health Innovations +2
16 Dec 2021
Venture Round €10.00M 5
Invest-NL Kreos Capital Inkef
Invest-NL, Kreos Capital +3
08 Jul 2020
Series B €10.00M 1
EQT Life Sciences
20 Jan 2016
Series A Undisclosed -
07 Mar 2013

Latest News

View All
ViCentra secures $13M to accelerate growth and advance next-gen insulin system — Tech
ViCentra secures $13M to accelerate growth and advance next-gen insulin system
Tech Jan 08, 2026
London-based GHO Capital boosts healthcare fund size by 25% to €2.5 billion — Eu-startups
London-based GHO Capital boosts healthcare fund size by 25% to €2.5 billion
Eu-startups Oct 28, 2025
Dutch Men’s health startup Fellos lands €2 million to tackle sensitive issues like ED and PE through... — Eu-startups
Dutch Men’s health startup Fellos lands €2 million to tackle sensitive issues like ED and PE through telehealth
Eu-startups Oct 07, 2025
Dutch MedTech startup ViCentra raises €72.4 million to scale their Kaleido insulin patch pump — Eu-startups
Dutch MedTech startup ViCentra raises €72.4 million to scale their Kaleido insulin patch pump
Eu-startups Sep 05, 2025

Kaleido Alternatives & Competitors

View All Alternatives
Kaleido vs
MicroTech Medical
MicroTech Medical China

We are dedicated to helping people with diabetes lead a healthy life.

Series D
43 employees
Health Care, Manufacturing
Compare Kaleido vs MicroTech Medical
Kaleido vs
Insulet Corporation
Insulet Corporation United States

Creating a better world through innovative technology that improves the lives of people with diabete...

Series E
3587 employees
Health Care, Medical Devices
Compare Kaleido vs Insulet Corporation
Kaleido vs
Rotech Healthcare
Rotech Healthcare United States

We provide quality home respiratory & medical equipment, helping patients lead a more comfortable an...

Acquired
2592 employees
Health Care, Medical Devices
View all alternatives

FAQ About Kaleido

Kaleido, insulin pump therapy designed to help you live life on your own terms.
Kaleido was founded in 2013.
Kaleido is headquartered in The Netherlands.
Kaleido operates in Health Care and Medical Devices. Its work centres on Insulin Pump Therapy, Diabetes Management, Innovative Healthcare Products and User-Centric Design. Its customers include Adults with Type 1 Diabetes, Healthcare Providers and Caregivers of Diabetic Patients.
Kaleido has a B2C, D2C and B2B2C business model. Its revenue comes from Product Sales, Subscription and Service Fee.
Kaleido has approximately 215 employees.
Kaleido has completed 6 funding rounds, raising a total of $170.40M. The latest funding stage is Series D.
Kaleido offers: Automated Insulin Delivery, Diabetes Data Insights, Customizable Wearable Pumps, Healthcare Consultation Support.
Top alternatives and competitors to Kaleido include MicroTech Medical, Insulet Corporation, Rotech Healthcare, Catalyst OrthoScience , Metamodix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kaleido and MicroTech Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Kaleido, https://bouncewatch.com/company/vicentra, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes